Ubs Asset Management Americas Inc Reata Pharmaceuticals Inc Transaction History

Ubs Asset Management Americas Inc

$381 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$30.85 - $93.17 $62,563 - $188,948	2,028 Added 8.52%	25,836 $2.35 Million
Q4 2022 Feb 14, 2023	BUY	$22.15 - $42.11 $34,111 - $64,849	1,540 Added 6.92%	23,808 $904,000
Q3 2022 Nov 14, 2022	SELL	$19.41 - $36.49 $197,186 - $370,701	-10,159 Reduced 31.33%	22,268 $559,000
Q2 2022 Aug 12, 2022	BUY	$20.71 - $36.5 $77,496 - $136,583	3,742 Added 13.05%	32,427 $985,000
Q1 2022 May 16, 2022	BUY	$24.12 - $39.6 $63,749 - $104,662	2,643 Added 10.15%	28,685 $939,000
Q4 2021 Feb 14, 2022	SELL	$25.61 - $110.96 $129,663 - $561,790	-5,063 Reduced 16.28%	26,042 $686,000
Q3 2021 Nov 15, 2021	SELL	$100.0 - $143.02 $84,900 - $121,423	-849 Reduced 2.66%	31,105 $3.13 Million
Q2 2021 Aug 16, 2021	SELL	$78.27 - $151.29 $475,411 - $918,935	-6,074 Reduced 15.97%	31,954 $4.52 Million
Q1 2021 May 14, 2021	SELL	$94.25 - $132.81 $35,061 - $49,405	-372 Reduced 0.97%	38,028 $3.79 Million
Q4 2020 Mar 01, 2021	BUY	$102.03 - $184.62 $571,061 - $1.03 Million	5,597 Added 17.06%	38,400 $4.75 Million
Q3 2020 Nov 13, 2020	BUY	$93.53 - $163.34 $78,471 - $137,042	839 Added 2.62%	32,803 $3.2 Million
Q2 2020 Aug 14, 2020	BUY	$126.3 - $176.56 $1.07 Million - $1.5 Million	8,477 Added 36.09%	31,964 $4.99 Million
Q1 2020 May 15, 2020	BUY	$124.16 - $247.74 $186,488 - $372,105	1,502 Added 6.83%	23,487 $3.39 Million
Q4 2019 Feb 14, 2020	BUY	$74.57 - $217.92 $175,985 - $514,291	2,360 Added 12.03%	21,985 $4.49 Million
Q3 2019 Nov 14, 2019	BUY	$71.26 - $95.75 $324,945 - $436,620	4,560 Added 30.27%	19,625 $1.58 Million
Q2 2019 Aug 15, 2019	BUY	$77.72 - $94.35 $364,662 - $442,690	4,692 Added 45.23%	15,065 $0
Q1 2019 May 14, 2019	BUY	$51.9 - $101.79 $84,700 - $166,121	1,632 Added 18.67%	10,373 $0
Q3 2018 Nov 14, 2018	BUY	$35.64 - $92.06 $311,529 - $804,696	8,741 New	8,741 $0
Q2 2018 Aug 14, 2018	SELL	$19.94 - $40.96 $3.49 Million - $7.17 Million	-175,096 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$20.0 - $30.19 $178,020 - $268,721	-8,901 Reduced 4.84%	175,096 $0
Q4 2017 Feb 09, 2018	SELL	$22.39 - $33.27 $62,535 - $92,923	-2,793 Reduced 1.5%	183,997 $0
Q3 2017 Nov 13, 2017	BUY	$26.29 - $31.88 $4.91 Million - $5.95 Million	186,790	186,790 $0

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account